TANIKA LEWIS: Open Payments
NPI 1538616263 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 62 payments from 12 companies in 2025. Trend: 2023 $307 · 2024 $483 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $203 |
| Neurocrine BioSciences, Inc. | 10 | $195 |
| ABBVIE INC. | 12 | $144 |
| Vanda Pharmaceuticals Inc. | 7 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $137 |
| Otsuka America Pharmaceutical, Inc. | 7 | $121 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Lundbeck LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $26 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, VIVITROL, FANAPT, REXULTI, HETLIOZ.
Industry payments across NC — which companies pay providers there.
